The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesothelioma community.
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.
An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.
Once the law goes into effect, any individual caught selling, buying, or distributing products containing asbestos will face a $2,500 fine.
The International Symposium on Malignant Mesothelioma, held at the Hyatt Regency Hotel in Bethesda, Maryland, lasted for three days, from March 25th–27th.